Product Information

DIFLUPREDNATE 0.05% EYE DROP is a generic product labeled by Leading Pharma, LLC, priced at $8.0544 per ML under NDC 69315032905. Its NADAC has been published 77 times since Jun 4, 2025.

FDA first approved this application on Dec 13, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DIFLUPREDNATE 0.05% EYE DROP

DIFLUPREDNATE
$8.0544per ML

Strength

.5 mg/mL

NDC

69315032905

Classification

Generic

Dosage Form

EMULSION

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

DIFLUPREDNATE

Approval Type

Generic (ANDA)

FDA Application

ANDA219441

FDA Approved

12/13/2024

TE Code

AB

On Market Since

2/18/2025

Price Statistics

The NADAC for DIFLUPREDNATE 0.05% EYE DROP has been published 77 times since Jun 4, 2025, and over the history we have for it it has declined 36.0%. The table below summarizes its recorded NADAC range and movement.

Current price$8.0544 per ML
All-time high$12.5868 (Jun 11, 2025)
All-time low$7.0479 (Jun 17, 2026)
52-week high$10.4599
52-week low$7.0479
Median price$9.7858
Average price$9.6967
Largest weekly change+20.4% (Aug 19, 2026)
Weeks tracked77
Tracking sinceJun 4, 2025

Price History

1W

-11.2%

1M

-16.8%

3M

-9.7%

6M

-0.7%

1Y

-19.8%

3Y

N/A

5Y

N/A

All

-36.0%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DIFLUPREDNATE 0.05% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for DIFLUPREDNATE 0.05% EYE DROP, manufactured by Leading Pharma, LLC, is $8.0544 per ML (NDC 69315032905), effective Nov 18, 2026.

How has the price of DIFLUPREDNATE 0.05% EYE DROP changed over time?

Over the history we have for it, the NADAC for DIFLUPREDNATE 0.05% EYE DROP has declined 36.0%. It has been tracked across 77 weekly CMS publications since Jun 4, 2025.

What are the highest and lowest recorded NADAC prices for DIFLUPREDNATE 0.05% EYE DROP?

Since Jun 4, 2025, the NADAC for DIFLUPREDNATE 0.05% EYE DROP has ranged from a low of $7.0479 (Jun 17, 2026) to a high of $12.5868 (Jun 11, 2025), with a median of $9.7858 per ML.

Are there cheaper alternatives to DIFLUPREDNATE 0.05% EYE DROP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DIFLUPREDNATE 0.05% EYE DROP in a comparable dosage form, but none are currently priced below it.

Who manufactures DIFLUPREDNATE 0.05% EYE DROP?

DIFLUPREDNATE 0.05% EYE DROP (NDC 69315032905) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.